Skip to content

KYMR

Kymera Therapeutics, Inc.

Stock

$107.39−2.73 (−2.48%)Close Oct 2, 2026

Diluted EPS, 2025
−$3.69

Diluted EPS

Diluted EPS by fiscal year

PeriodEPSYoY
2025−$3.69—
2024−$2.98—
2023−$2.52—
2022−$2.87—
2021−$2.09—
2020−$3.15—
2019−$24.28—